MAPK8 and urinary bladder carcinoma: However, SP600125, a specific inhibitor of JNK, did not attenuate the sanguinarine-induced apoptosis (Fig. 6C), suggesting that ROS-dependent JNK activation by sanguinarine cannot act as a mediator of the proapoptotic effects of sanguinarine in human bladder cancer cells.